Français
ItalianoBond AbbVie 1.75% ( USU0029QAB24 ) in USD
| Issuer | AbbVie | ||||||
| Market price | 100.00 % ⇌ | ||||||
| Country |  United States
|
||||||
| ISIN code |
 USU0029QAB24 ( in USD )
|
||||||
| Interest rate | 1.75% per year ( payment 2 times a year) | ||||||
| Maturity | 06/11/2017 - Bond has expired | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 4 000 000 000 USD | ||||||
| Cusip | U0029QAB2 | ||||||
| Standard & Poor's ( S&P ) rating | NR | ||||||
| Moody's rating | NR | ||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. AbbVie's US$4,000,000,000 1.75% bond (CUSIP: U0029QAB2, ISIN: USU0029QAB24), issued in the United States, matured on 06/11/2017 and has been redeemed at 100% of its face value. |
||||||
| |||||||